Zurich Cantonal Bank’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $673K | Buy |
6,448
+911
| +16% | +$95.1K | ﹤0.01% | 1471 |
|
|
2025
Q1 | $646K | Sell |
5,537
-1,479
| -21% | -$172K | ﹤0.01% | 1433 |
|
|
2024
Q4 | $594K | Buy |
7,016
+1,817
| +35% | +$154K | ﹤0.01% | 1526 |
|
|
2024
Q3 | $467K | Hold |
5,199
| – | – | ﹤0.01% | 1607 |
|
|
2024
Q2 | $419K | Hold |
5,199
| – | – | ﹤0.01% | 1609 |
|
|
2024
Q1 | $415K | Sell |
5,199
-635
| -11% | -$50.7K | ﹤0.01% | 1600 |
|
|
2023
Q4 | $464K | Sell |
5,834
-1,890
| -24% | -$150K | ﹤0.01% | 1552 |
|
|
2023
Q3 | $540K | Buy |
7,724
+872
| +13% | +$60.9K | ﹤0.01% | 1351 |
|
|
2023
Q2 | $492K | Buy |
6,852
+1,129
| +20% | +$81.1K | ﹤0.01% | 1361 |
|
|
2023
Q1 | $353K | Buy |
5,723
+1,031
| +22% | +$63.6K | ﹤0.01% | 1511 |
|
|
2022
Q4 | $362K | Sell |
4,692
-239
| -5% | -$18.4K | ﹤0.01% | 1440 |
|
|
2022
Q3 | $220K | Buy |
4,931
+1,167
| +31% | +$52.1K | ﹤0.01% | 1693 |
|
|
2022
Q2 | $144K | Sell |
3,764
-63
| -2% | -$2.41K | ﹤0.01% | 1985 |
|
|
2022
Q1 | $158K | Buy |
3,827
+831
| +28% | +$34.3K | ﹤0.01% | 2040 |
|
|
2021
Q4 | $113K | Hold |
2,996
| – | – | ﹤0.01% | 2438 |
|
|
2021
Q3 | $99K | Hold |
2,996
| – | – | ﹤0.01% | 2340 |
|
|
2021
Q2 | $202K | Hold |
2,996
| – | – | ﹤0.01% | 1800 |
|
|
2021
Q1 | $170K | Sell |
2,996
-539
| -15% | -$30.6K | ﹤0.01% | 1870 |
|
|
2020
Q4 | $288K | Buy |
3,535
+507
| +17% | +$41.3K | ﹤0.01% | 1611 |
|
|
2020
Q3 | $216K | Hold |
3,028
| – | – | ﹤0.01% | 1538 |
|
|
2020
Q2 | $249K | Buy |
3,028
+471
| +18% | +$38.7K | ﹤0.01% | 1385 |
|
|
2020
Q1 | $150K | Buy |
2,557
+373
| +17% | +$21.9K | ﹤0.01% | 1363 |
|
|
2019
Q4 | $226K | Hold |
2,184
| – | – | ﹤0.01% | 1270 |
|
|
2019
Q3 | $44K | Sell |
2,184
-607
| -22% | -$12.2K | ﹤0.01% | 2123 |
|
|
2019
Q2 | $72K | Buy |
+2,791
| New | +$72K | ﹤0.01% | 1827 |
|